ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Inozyme Pharma Inc

Inozyme Pharma Inc (INZY)

2.99
0.18
(6.41%)
Closed 21 December 8:00AM
2.99
0.00
( 0.00% )
Pre Market: 9:18PM

Inozyme Pharma Inc Financial Summary

The current INZY market cap is 192.08M. The company's latest EPS is USD -1.1079 and P/E is -2.70.

Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00000
Operating Income -16.39M-18.07M-22.81M-24.35M-27.66M
Net Income -15.58M-16.64M-21.54M-23.35M-27.03M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00000
Operating Income -20.81M-57.04M-56.65M-68.68M-75.65M
Net Income -19.72M-56.42M-56.62M-67.06M-71.17M
Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 150.93M205.7M200.85M176.94M155.71M
Total Liabilities 45.34M45.49M60.37M58.11M61.29M
Total Equity 105.59M160.21M140.48M118.84M94.42M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 47.94M169.36M123.54M139.2M200.85M
Total Liabilities 81.16M11.26M14.27M20.8M60.37M
Total Equity -33.22M158.1M109.27M118.39M140.48M
Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -33.32M-52.19M-70.68M-24.53M-48.19M
Investing -2.56M-47.18M-53.65M10.39M28.21M
Financing 43.74M113.45M125.97M159k617k
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -18.81M-35.97M-48.15M-57.76M-70.68M
Investing -8.39M-117.18M42.8M-5.4M-53.65M
Financing 22.97M149.81M609k72.79M125.97M
Market Cap 192.08M
Price to Earnings Ratio -2.70
Price to Sales Ratio 0
Price to Cash Ratio 5.55
Price to Book Ratio 1.37
Dividend Yield -

Share Statistics

Shares Outstanding 64.24M
Average Volume (1 week) 627.26k
Average Volume (1 Month) 946.9k
52 Week Change -32.96%
52 Week High 7.795
52 Week Low 2.385
Spread (Intraday) 1.8 (41.38%)

Company Info

Company Name Inozyme Pharma Inc
Address corporation trust center 1209 orange st
wilmington, delaware 19801
Website https://www.inozyme.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock